biguanides and Cancer of Ovary
biguanides has been researched along with Cancer of Ovary in 3 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"Olaparib is a PARP inhibitor approved for maintenance therapy following platinum-based chemotherapy." | 1.56 | Biguanides in combination with olaparib limits tumorigenesis of drug-resistant ovarian cancer cells through inhibition of Snail. ( Amin, O; Baloch, T; Bithras, J; Kessous, R; Kogan, L; Laskov, I; López-Ozuna, VM; Wang, Q; Yasmeen, A, 2020) |
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors
Authors | Studies |
---|---|
Wang, Q | 1 |
López-Ozuna, VM | 1 |
Baloch, T | 1 |
Bithras, J | 1 |
Amin, O | 1 |
Kessous, R | 1 |
Kogan, L | 1 |
Laskov, I | 1 |
Yasmeen, A | 2 |
Kenny, HA | 1 |
Lal-Nag, M | 1 |
White, EA | 1 |
Shen, M | 1 |
Chiang, CY | 1 |
Mitra, AK | 1 |
Zhang, Y | 1 |
Curtis, M | 1 |
Schryver, EM | 1 |
Bettis, S | 1 |
Jadhav, A | 1 |
Boxer, MB | 1 |
Li, Z | 1 |
Ferrer, M | 1 |
Lengyel, E | 1 |
Segal, ED | 1 |
Beauchamp, MC | 1 |
Rosenblatt, J | 1 |
Pollak, M | 1 |
Gotlieb, WH | 1 |
Other Studies
3 other studies available for biguanides and Cancer of Ovary
Article | Year |
---|---|
Biguanides in combination with olaparib limits tumorigenesis of drug-resistant ovarian cancer cells through inhibition of Snail.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biguanides; Carcinogenesis; Cell Line, Tumor; Cell M | 2020 |
Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy.
Topics: Animals; Antineoplastic Agents; Benzophenanthridines; Biguanides; Cantharidin; Cell Adhesion; Cell M | 2015 |
Relevance of the OCT1 transporter to the antineoplastic effect of biguanides.
Topics: Adenylate Kinase; Antineoplastic Agents; Biguanides; Cell Line, Tumor; Drug Resistance, Neoplasm; Fe | 2011 |